การติดเชื้อไวรัสจากการปฏิบัติงานของบุคลากรทางการแพทย์
Article Sidebar
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
CDC. Updated US. Public health service guidelines for the management of occupational exposures to HBV, HCV and HIV and recommendations for postexposure prophylaxis. MMWR 2001; 50 (No RR-11): 1-52.
Bell DM. Occupational risk of human immunodeficiency virus infection in health-care workers: an overview. Am J Med 1997; 102: 9-15.
Shih CC, Kaneshima H, Rabin L, Namikawa R, Sager P, McGowen J, et al. Postexpoosure prophylaxis with zidovudine suppresses human immunodeficiency virus type 1 infection in SCID-hu mice in a time-dependent manner. J Infect Dis 1991: 163: 625-7.
Otten RA, Smith DK, Adams DR, Pullium JK, Jackson E, Kim CN, et al. Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol 2000; 74: 9771-5.
Ridzon R, Gallagher K, Ciesielski C, Ginsberg MB, Robertson BJ, Luo CC, et al. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needlesteck injury. N Engl J Med 1997; 336: 919-22.
CDC.Updated U.S. Public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR 2005; 54 (No.RR-9): 1-17.
Cattelan AM, Erne E, Salatino A, Trevenzoli M, Caretta G, Meneqhetti F, et al. Severe hepatic failure related to nevirapine treatment. Clin Infect Dis 1999; 29: 455-6.